Similar articles

• Accelerated fractionation (AF) in head and neck cancers.

  Esassolak M, Yalman D, Anacak Y, Ozkök S, Haydaroğlu A. Esassolak M, et al. Radiother Oncol. 1998 Apr;47(1):103-4. Radiother Oncol. 1998. PMID: 9632302 No abstract available.
• Accelerated fractionation (AF) in head and neck cancers.

  Jones B, Dale RG. Jones B, et al. Radiother Oncol. 1998 Apr;47(1):107-8. doi: 10.1016/s0167-8140(98)00004-8. Radiother Oncol. 1998. PMID: 9632304 No abstract available.
• Accelerated vs. conventionally fractionated adjuvant radiotherapy in high-risk head and neck cancer: a meta-analysis.

  Matuschek C, Haussmann J, Bölke E, Gripp S, Schuler PJ, Tamaskovics B, Gerber PA, Djiepmo-Njanang FJ, Kammers K, Plettenberg C, Anooshahr B, Orth K, Budach W. Matuschek C, et al. Radiat Oncol. 2018 Oct 4;13(1):195. doi: 10.1186/s13014-018-1133-8. Radiat Oncol. 2018. PMID: 30286777 Free PMC article.
• New advances in high-technology radiotherapy for head and neck cancer.

  Kubicek GJ, Machtay M. Kubicek GJ, et al. Hematol Oncol Clin North Am. 2008 Dec;22(6):1165-80, viii. doi: 10.1016/j.hoc.2008.08.014. Hematol Oncol Clin North Am. 2008. PMID: 19010266 Review.
• Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis.

  Bourhis J, Overgaard J, Audry H, Ang KK, Saunders M, Bernier J, Horiot JC, Le Maître A, Pajak TF, Poulsen MG, O'Sullivan B, Dobrowsky W, Hliniak A, Skladowski K, Hay JH, Pinto LH, Fallai C, Fu KK, Sylvester R, Pignon JP; Meta-Analysis of Radiotherapy in Carcinomas of Head and neck (MARCH) Collaborative Group. Bourhis J, et al. Lancet. 2006 Sep 2;368(9538):843-54. doi: 10.1016/S0140-6736(06)69121-6. Lancet. 2006. PMID: 16950362 Review.